Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
4
×
san francisco blog main
startups
4
×
abbvie
boston blog main
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
national
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adverum biotechnologies
alzheimer's disease
amgen
astrazeneca
biogen
boston top stories
cancer
cancer immunotherapy
What
ceo
4
×
acquisitions
bio
drug
roundup
biggest
daniel
gilead
o’day
sciences
albert
announced
athena
biotech
bourla
build
buy
cancer
chief
collabs
company
company’s
countouriotis
covid
crispr
deal
debut
dyne’s
financing
future
gets
gilead’s
help
imports
introduce
ipo
maker
maps
measured
medical
Language
unset
unknown
Current search:
ceo
×
startups
×
" san diego top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push